694503-62-3

Upstream product

• 59398-98-0 (2-phenyl-1,3-oxazol-4-yl)methanol 
• 675147-97-4 5-(tert-butyldiphenylsilyloxymethyl)-4-(methoxymethoxymethyl)-2-phenyl-1,3-oxazole 
• 675148-95-5 [5-(tert-butyldiphenylsilyloxymethyl)-2-phenyl-1,3-oxazol-4-yl]methanol 
• 675147-96-3 (4-methoxymethoxymethyl-2-phenyl-oxazol-5-yl)-methanol 
• 441356-85-0 4-methoxymethoxymethyl-2-phenyl-5-oxazolecarbaldehyde 
• 441356-84-9 4-(methoxymethoxymethyl)-2-phenyl-1,3-oxazole 
• 250602-89-2 methyl (E)-4-[(4-hydroxybenzyloxy)imino]-4-phenylbutyrate 

Relevant academic research and scientific papers

Studies on non-thiazolidinedione antidiabetic agents. 3. Preparation and biological activity of the metabolites of TAK-559

Preparation and biological activity of the metabolites of the potent antihyperglycemic and antihyperlipidemic agent, (E)-4-{4-[(5-methyl-2-phenyl-1, 3-oxazol-4-yl)methoxy]benzyloxyimino}-4-phenylbutyric acid (TAK-559) (1), were investigated. Metabolites M